Ruxolitinib - Latest Advances

Real-world experience with pacritinib for patients with myelofibrosis refractory to ruxolitinib: a report of three cases.

Journal: Hospital practice (1995)

Published: October 17, 2025

Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?

Journal: Expert review of clinical pharmacology

Published: October 16, 2025

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 15, 2025

Effectiveness and safety of belumosudil in 20 patients with chronic graft-versus-host disease

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: October 14, 2025

The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: October 14, 2025

Efficacy of ruxolitinib and prognostic factors in patients with myelofibrosis stratified by age

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: October 14, 2025

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Journal: The Medical letter on drugs and therapeutics

Published: October 08, 2025

Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis.

Journal: Journal of drugs in dermatology : JDD

Published: October 02, 2025

Real-World Use of Topical Ruxolitinib in Vitiligo: A Retrospective Cross-Sectional Mixed-Methods Infodemiology Study of the r/Vitiligo Subreddit.

Journal: Journal of medical Internet research

Published: October 01, 2025

Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry

Journal: Se pu = Chinese journal of chromatography

Published: September 24, 2025

Ruxolitinib Meets a Forgotten Malady.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 19, 2025

Erratum: Uemura Y, Yamamoto M, Ishimura M, et al. JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. Blood Neoplasia. 2025;2(1):100053.

Journal: Blood neoplasia

Published: September 15, 2025

Filters

Real-world experience with pacritinib for patients with myelofibrosis refractory to ruxolitinib: a report of three cases.

Real-world experience with pacritinib for patients with myelofibrosis refractory to ruxolitinib: a report of three cases.

Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?

Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial.

Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial.

Effectiveness and safety of belumosudil in 20 patients with chronic graft-versus-host disease

Effectiveness and safety of belumosudil in 20 patients with chronic graft-versus-host disease

The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations

The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations

Efficacy of ruxolitinib and prognostic factors in patients with myelofibrosis stratified by age

Efficacy of ruxolitinib and prognostic factors in patients with myelofibrosis stratified by age

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis.

Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis.

Real-World Use of Topical Ruxolitinib in Vitiligo: A Retrospective Cross-Sectional Mixed-Methods Infodemiology Study of the r/Vitiligo Subreddit.

Real-World Use of Topical Ruxolitinib in Vitiligo: A Retrospective Cross-Sectional Mixed-Methods Infodemiology Study of the r/Vitiligo Subreddit.

Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry

Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry

Ruxolitinib Meets a Forgotten Malady.

Ruxolitinib Meets a Forgotten Malady.

Erratum: Uemura Y, Yamamoto M, Ishimura M, et al. JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. Blood Neoplasia. 2025;2(1):100053.

Erratum: Uemura Y, Yamamoto M, Ishimura M, et al. JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. Blood Neoplasia. 2025;2(1):100053.